Efficacy & Safety of Quetiapine Fumarate (SEROQUEL) & Placebo in the Treatment of Acutely Ill Patients With Schizophrenia

Completed · Phase 3

Conditions studied: Schizophrenia

In brief

The purpose of this study is to demonstrate superior efficacy of sustained release quetiapine compared to placebo in patients with schizophrenia after receiving treatment for up to 6 weeks.

Key facts

Study ID

NCT00085891

Run by

AstraZeneca

People needed

535

Starts

2004-06-01

Expected to finish

2005-09-01

Last updated by the study team

2009-03-25

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is able to provide written informed consent before beginning any study related procedures
• Patient has a documented clinical diagnosis of schizophrenia
• Patient is able to understand and comply with the requirements of the study, as judged by a study investigator

You may not qualify if…

• Patients with a history of non-compliance as judged by the study investigator
• Patients with a known lack of response to previous treatment with quetiapine
• Patients who have participated in another drug study within 4 weeks prior to enrollment into this study
• Patients who have previously participated in this study or study D1444C00132

Where it is running

• Research Site — Birmingham, Alabama, United States
• Research Site — Cerritos, California, United States
• Study site — Los Angeles, California, United States
• Research Site — San Diego, California, United States
• Research Site — Santa Ana, California, United States
• Research Site — Washington D.C., District of Columbia, United States
• Research Site — Miami, Florida, United States
• Study site — Oak Brook, Illinois, United States
• Research Site — Oakbrook Terrace, Illinois, United States
• Research Site — New Orleans, Louisiana, United States
• Research Site — Rockville, Maryland, United States
• Study site — Brighton, Massachusetts, United States
• Research Site — Jackson, Mississippi, United States
• Research Site — St Louis, Missouri, United States
• Research Site — Holliswood, New York, United States
• Research Site — Lawrence, New York, United States
• Research Site — Staten Island, New York, United States
• Research Site — Medina, Ohio, United States
• Research Site — Oklahoma City, Oklahoma, United States
• Research Site — Norristown, Pennsylvania, United States
• Research Site — Philadelphia, Pennsylvania, United States
• Research Site — Sioux Falls, South Dakota, United States
• Research Site — Memphis, Tennessee, United States
• Research Site — Austin, Texas, United States
• Research Site — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.